Sigma-Aldrich Shareholders Approve Merger with Merck

  • Author:
  • Published: 06 December 2014
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Merck KGaA
  • Associated Suppliers: Sigma-Aldrich, St. Louis, MO, USA | Merck KGaA, Darmstadt, Germany
thumbnail image: Sigma-Aldrich Shareholders Approve Merger with Merck

The shareholders of Sigma-Aldrich approved the merger with Merck at a special meeting held at the Sigma-Aldrich Life Science and Technology Center, St. Louis, MO, USA. With approximately 78 %, shareholders owning the required majority of the outstanding shares of Sigma-Aldrich approved the proposed transaction.

Shareholder approval was one of the conditions the transaction is subject to. According to the merger agreement, Merck will acquire all of the outstanding Sigma-Aldrich shares for $140 per share in cash.

Merck continues to expect the transaction, which is subject to regulatory approvals, to close in mid-year 2015. The acquisition had already unanimously been approved by Sigma-Aldrich’s Board of Directors in September 2014. A Merck shareholder vote is not required.

Article Views: 2872

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH